Results 311 to 320 of about 6,673,815 (394)

Enhancing lateral flow immunoassay performance for cardiac troponin I detection with pore-size tailored silica nanoparticles and smartphone-based "AdaptiScan" analysis. [PDF]

Front Bioeng Biotechnol
Ye S, Xu C, Li H, Feng S, Wang Y, Gao F.
europepmc   +1 more source

Protective effects of combined eptifibatide and ticagrelor in patients with unstable angina undergoing percutaneous coronary intervention: a single-center experience. [PDF]

BMC Cardiovasc Disord
Shi S, Ling Z, Gu S, Jiang T, Ling L.
europepmc   +1 more source

Biomarkers in heart failure: Traditional and emerging indicators for prognosis

ESC Heart Failure, Volume 12, Issue 3, Page 1535-1538, June 2025.
Arnold Péter Ráduly, László Nagy, Beáta Bódi, Zoltán Papp, Attila Borbély   +4 more
wiley   +1 more source

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

ESC Heart Failure, Volume 12, Issue 3, Page 1620-1629, June 2025.
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi, Gad Cotter, Beth A. Davison, Yonathan Freund, Adriaan A. Voors, Christopher Edwards, Maria Novosadova, Koji Takagi, Hamlet Hayrapetyan, Andranik Mshetsyan, Mayranush Drambyan, Alain Cohen‐Solal, Jozine M. ter Maaten, Jan Biegus, Piotr Ponikowski, Gerasimos Filippatos, Ovidiu Chioncel, Malha Sadoune, Tabassome Simon, Douglas L. Mann, Alexandre Mebazaa, Marco Metra   +21 more
wiley   +1 more source

High-Sensitivity Troponin: Finding a Meaningful Delta. [PDF]

J Cardiovasc Dev Dis
Wright CX, Wright DS, Hu JR, Gallegos C.
europepmc   +1 more source

Immune cell dynamics in heart failure: implicated mechanisms and therapeutic targets

ESC Heart Failure, Volume 12, Issue 3, Page 1739-1758, June 2025.
Abstract The relationship between heart failure (HF) and immune activation has garnered significant interest. Studies highlight the critical role of inflammation in HF, affecting cardiac structure and function. Despite promising anti‐inflammatory therapies, clinical trials have faced challenges, indicating an incomplete understanding of immune ...
Gen Li, Wu He, Dao Wen Wang
wiley   +1 more source

Short-term recurrent coronary artery thrombosis with acute myocardial infarction in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: a case report. [PDF]

Front Cardiovasc Med
Fu XG, Guo YH, Wang SC, Zhang WQ.
europepmc   +1 more source

Prognostic value of elevated cardiac troponin in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. [PDF]

Front Neurol
Zhao J, Gu S, Zhao X, Wang S, Pan Q, Zou C.   +5 more
europepmc   +1 more source

Cisplatin‐Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Platinum‐based chemotherapeutics, particularly cisplatin, are crucial in the treatment of various malignancies due to their strong antitumor effects. However, a significant side effect of cisplatin is muscle atrophy, which severely impairs physical strength, diminishes quality of life and complicates cancer therapy.
Ko‐Chieh Huang, Yi‐Fen Chiang, Mohamed Ali, Shih‐Min Hsia   +3 more
wiley   +1 more source